HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is a paper indexed in PICO Portal from OpenAlex.
How many citations does HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients have?
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients has 158 citations in the OpenAlex counts PICO Portal stores.
When was HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients published?
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients has 2005 year in the PICO Portal index.
What is the open-access status of HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients has closed oa status in the PICO Portal index.
What is the DOI of HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?
The DOI for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is on the source record.
What is the PMID of HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?
The PMID for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is on the source record.
What is the OpenAlex record for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?
The OpenAlex for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is on the source record.